Concert Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs.

Biotechnology

Pharmaceutical

Concert Pharmaceuticals

Concert Pharmaceuticals' headquarters in Lexington, MA, United States

James V. Cassella

Christine Boisclair

Jeffrey A. Munsie

Daniel Morse

Ken Goldenberg (Mitch)

K. Mitch Goldenberg

Justine E. Koenigsberg

Cameron J. Cowden

Bob Zelle

Nabil Uddin

Mara Veverbrants Perry

Joseph Farella

Richard H. Aldrich

Thomas G. Auchincloss Jr.

Jesper Høiland

Peter Barton Hutt

Wilfred E. Jaeger

Christine Van Heek

The Research and Development team at Concert Pharmaceuticals is dedicated to advancing the company's drug portfolio by leveraging the DCE Platform® to create innovative therapies. This multidisciplinary team collaborates on pharmaceutical development, clinical operations, regulatory affairs, and quality assurance to ensure the successful progression of drug candidates from conception through clinical trials, ultimately addressing critical unmet medical needs.

Research and Development

The Leadership Team at Concert Pharmaceuticals drives the strategic direction and operational effectiveness of the company. Comprising executives with expertise in pharmaceutical development, regulatory affairs, supply chain management, and corporate communications, the team collaborates to advance clinical-stage programs utilizing the DCE Platform®. Their collective focus is on developing innovative treatments while ensuring compliance, fostering investor relations, and optimizing organizational infrastructure to meet unmet patient needs.

Leadership Team

Concert Pharmaceuticals

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Concert Pharmaceuticals

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Related companies